397 related articles for article (PubMed ID: 21859955)
21. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
22. Target silencing of disease-associated B-lymphocytes by chimeric molecules in SCID model of pristane-induced autoimmunity.
Dimitrova I; Gesheva V; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
Lupus; 2010 Oct; 19(11):1261-71. PubMed ID: 20530521
[TBL] [Abstract][Full Text] [Related]
23. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
24. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
Brummel R; Roberts TL; Stacey KJ; Lenert P
Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
[TBL] [Abstract][Full Text] [Related]
25. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
26. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
Kobayashi T; Takahashi K; Nagai Y; Shibata T; Otani M; Izui S; Akira S; Gotoh Y; Kiyono H; Miyake K
Int Immunol; 2008 Jul; 20(7):881-91. PubMed ID: 18492657
[TBL] [Abstract][Full Text] [Related]
27. Cutting Edge: DNase II deficiency prevents activation of autoreactive B cells by double-stranded DNA endogenous ligands.
Pawaria S; Moody K; Busto P; Nündel K; Choi CH; Ghayur T; Marshak-Rothstein A
J Immunol; 2015 Feb; 194(4):1403-7. PubMed ID: 25601924
[TBL] [Abstract][Full Text] [Related]
28. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
[TBL] [Abstract][Full Text] [Related]
29. IL-17 promotes murine lupus.
Amarilyo G; Lourenço EV; Shi FD; La Cava A
J Immunol; 2014 Jul; 193(2):540-3. PubMed ID: 24920843
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.
Capolunghi F; Rosado MM; Cascioli S; Girolami E; Bordasco S; Vivarelli M; Ruggiero B; Cortis E; Insalaco A; Fantò N; Gallo G; Nucera E; Loiarro M; Sette C; De Santis R; Carsetti R; Ruggiero V
Rheumatology (Oxford); 2010 Dec; 49(12):2281-9. PubMed ID: 20739362
[TBL] [Abstract][Full Text] [Related]
31. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.
Halcomb KE; Musuka S; Gutierrez T; Wright HL; Satterthwaite AB
Mol Immunol; 2008 Dec; 46(2):233-41. PubMed ID: 18849077
[TBL] [Abstract][Full Text] [Related]
32. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
Kim J; Gross JA; Dillon SR; Min JK; Elkon KB
Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838
[TBL] [Abstract][Full Text] [Related]
33. Antinucleosome autoantibodies bind directly to cell lines in vitro and via the FcgammaRIIB receptor to B lymphocytes in vivo: a role for immune complexes in interactions between antinucleosome IgG2a and B cells of BXSB lupus mice.
Li X; Egorina E; Bertelsen EL; Dahlen H; Hannestad K
Scand J Immunol; 2004; 60(1-2):121-33. PubMed ID: 15238081
[TBL] [Abstract][Full Text] [Related]
34. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
[TBL] [Abstract][Full Text] [Related]
35. Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation.
Jackson SW; Scharping NE; Kolhatkar NS; Khim S; Schwartz MA; Li QZ; Hudkins KL; Alpers CE; Liggitt D; Rawlings DJ
J Immunol; 2014 May; 192(10):4525-32. PubMed ID: 24711620
[TBL] [Abstract][Full Text] [Related]
36. Cognate interaction plays a key role in the surveillance of autoreactive B cells in induced mixed bone marrow chimerism in BXSB lupus mice.
Takeuchi E; Shinohara N; Takeuchi Y
Autoimmunity; 2011 Aug; 44(5):363-72. PubMed ID: 21244333
[TBL] [Abstract][Full Text] [Related]
37. B cell tolerance to self in systemic autoimmunity.
Zouali M
Arch Immunol Ther Exp (Warsz); 2001; 49(5):361-5. PubMed ID: 11798134
[TBL] [Abstract][Full Text] [Related]
38. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.
Barrat FJ; Meeker T; Gregorio J; Chan JH; Uematsu S; Akira S; Chang B; Duramad O; Coffman RL
J Exp Med; 2005 Oct; 202(8):1131-9. PubMed ID: 16230478
[TBL] [Abstract][Full Text] [Related]
39. B cell-intrinsic TLR9 expression is protective in murine lupus.
Tilstra JS; John S; Gordon RA; Leibler C; Kashgarian M; Bastacky S; Nickerson KM; Shlomchik MJ
J Clin Invest; 2020 Jun; 130(6):3172-3187. PubMed ID: 32191633
[TBL] [Abstract][Full Text] [Related]
40. Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice.
Trendelenburg M; Manderson AP; Fossati-Jimack L; Walport MJ; Botto M
Immunology; 2004 Sep; 113(1):80-8. PubMed ID: 15312138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
